
22/08/2025
📑Title: The Importance of Being as Profile (Mixed Chelate–Copper (II) Complexes and Their In Vitro and In Vivo Activities)
Authors: Zenayda Aguilar-Jiménez et al.
📌
In this review, we present a timeline that shows the origin of mixed chelate copper (II) complexes, registered as Mark Title Casiopeínas®, as the first copper (II) compounds proposed as anticancer drugs in 1988 and 1992. In the late twentieth century, the use of essential metals as anticancer agen...